Our substantial know-how in RNA engineering makes us uniquely suited to unlock therapeutic delivery of siRNA and LNP payloads beyond the liver. The team at Velocity Sciences is developing its own pipeline of therapeutic products for patients with serious diseases in hematology. Stay tuned for us to emerge from “stealth mode”.